- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Refractory Mixed Phenotype Acute Leukemia
Explore clinical trials studying Refractory Mixed Phenotype Acute Leukemia. Study availability and eligibility vary by location and protocol.
8 public trials
5 recruiting studies
Refractory Mixed Phenotype Acute Leukemia trial results
NCT03128034
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03670966
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06928662
- Conditions
- Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Bone Marrow Diseases, +32 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
NCT04797767
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
Active, not recruiting
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
NCT02879695
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05146739
- Conditions
- Acute Myeloid Leukemia Post Cytotoxic Therapy, Bone Marrow Diseases, Hematologic Diseases, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States